Skip to main content

Human Research Protection Program

  • The mission of Allina Health's Human Research Protection Program (HRPP), and its Institutional Review Board (IRB), is to protect the rights and welfare of subjects involved in human research overseen by this organization. This includes human subjects research involving Allina Health employees, facilities, patients or data.

    Allina Health Institutional Review Board (IRB)

    Allina Health has an internal Institutional Review Board (IRB) that reviews and provides ongoing IRB oversight for studies and has engaged a number of external IRBs to help with the review of research.

    The Allina Health HRPP uses the electronic submission system, IRBNet (, for the submission and record-keeping of studies to the IRB. All new studies, regardless of reviewing IRB, should be submitted in IRBNet.

    All submission requirements, instructions, and forms are located in the Forms and Templates tab when you log in to IRBNet. To access these documents, researchers will need to set up a user profile and affiliate with Allina Health.

    Instructions for Creating an IRBNet User Profile

    IRBNet User Guide

    More Allina Health IRB information

    IRB Meeting Schedule

    HRPP/IRB Standard Operating Procedures

    IRB Review Fees

    CITI Training Information

    Translated Short Forms for Consent

    All research participants must sign an informed consent in a language they can understand. 

    An increasing number of research studies in English-speaking countries include participants who may not understand the English language. It is vital that all participants have an opportunity to understand enough about the study and the elements of consent in order for them to make an informed decision about participating in the research study. This means that consent must be obtained using language that non-English-speaking participants understand. To implement this requires either written translation or oral presentation in the relevant non-English language by a person who is fluent in both English and the other language. 

    If it is known in advance that a language other than English will be spoken by the potential study population, an informed consent, in the language of the consenting participant, must be submitted to the IRB after the submitted consent form is approved and before the study begins. "Known in advance" means that the PI is targeting a population that is anticipated or likely to have non-English speaking participants. 

    If it is not known in advance that a potential participant does not speak English, a short form of the informed consent in a language understandable to the participant must be available and used together with a translator reading the consent given to all participants. The participant would be required to sign the written short form in addition to being provided with a written summary of the research in the English language. A translator must be available to read the long English version of the informed consent form to the participant in the participant's language. The basic regulations are stated in 45 CFR 46.116 and 117a and b.

    The translated short forms should be used when consenting subjects who do not speak or read English, or have limited proficiency in oral or written English, and the full consent form has not been translated into the subject's language. 

    For more information on using a translated short form, please see Section 12.8 and 12.9.1 in the Allina Health HRPP/IRB Standard Operating Procedures.

    Chinese: Simplified 
    Chinese: Traditional